neonat
diarrhea
remain
primari
caus
mortal
dairi
calv
around
world
optim
treatment
protocol
need
main
goal
therapi
restor
hydrat
electrolyt
concentr
correct
strong
ion
metabol
acidemia
provid
nutrit
support
administr
oral
electrolyt
solut
oe
long
primari
method
use
treat
neonat
diarrhea
human
calv
oe
capabl
address
primari
goal
therapi
calv
moder
dehydr
hypothes
oral
electrolyt
would
good
better
small
volum
intraven
iv
subcutan
sc
fluid
therefor
main
goal
studi
compar
abil
commerci
avail
oral
electrolyt
solut
oe
administ
alon
combin
hyperton
salin
small
volum
iv
sc
fluid
therapi
resuscit
calv
diarrhea
thirtythre
holstein
calv
age
util
clinic
trial
diarrhea
dehydr
induc
ad
sucros
milk
replac
addit
hydrochlorothiazid
spironolacton
given
oral
furosemid
intramuscularli
depress
statu
clinic
hydrat
score
fecal
consist
bodi
weight
record
regular
interv
treatment
began
calv
sever
diarrhea
decreas
plasma
volum
least
calv
randomli
assign
treatment
group
calv
per
group
oe
oe
hyperton
salin
mlkg
iv
iv
fluid
lactat
ringer
l
sc
fluid
lactat
ringer
l
treatment
given
h
chang
plasma
volum
blood
ph
electrolyt
level
physic
examin
score
determin
therapi
h
treatment
treatment
ultim
success
improv
hydrat
well
increas
blood
ph
howev
anim
group
receiv
oe
much
faster
resuscit
either
iv
sc
fluid
group
conclus
oral
electrolyt
product
remain
gold
standard
resuscit
diarrheic
calv
moder
dehydr
acidemia
like
perform
better
small
volum
iv
lactat
ringer
solut
subcutan
fluid
poor
treatment
option
use
support
therapi
follow
initi
correct
hypovolemia
metabol
acidosi
neonat
diarrhea
major
sourc
econom
loss
dairi
industri
lead
caus
prewean
calf
mortal
countri
reiten
et
al
uri
et
al
treatment
primarili
focus
correct
dehydr
increas
blood
ph
correct
acidemia
restor
electrolyt
concentr
provid
nutrit
support
smith
berchtold
sever
differ
treatment
use
achiev
goal
includ
oral
electrolyt
intraven
iv
fluid
subcutan
sc
fluid
therapi
vari
result
accord
world
health
organ
develop
oral
rehydr
therapi
one
signific
advanc
human
medicin
centuri
administr
oral
electrolyt
solut
oe
often
primari
method
use
treat
neonat
diarrhea
human
hartl
et
al
binder
et
al
calv
smith
trefz
et
al
oral
electrolyt
solut
prefer
treatment
produc
inexpens
easi
administ
onfarm
provid
easi
way
administ
larg
amount
fluid
good
efficaci
anim
still
partial
function
gastrointestin
tract
yet
larg
divers
product
product
qualiti
market
may
influenc
success
electrolyt
therapi
lead
confus
evalu
treatment
success
smith
smith
exampl
product
low
sodium
concentr
wherea
other
alkalin
agent
buffer
correct
acidemia
therefor
produc
may
impress
oe
consist
effect
treat
calf
diarrhea
use
poor
qualiti
product
diarrheic
calv
iv
fluid
use
smith
berchtold
use
sc
fluid
therapi
remain
common
despit
lack
data
support
efficaci
rout
administr
calv
lactat
ringer
solut
lr
common
isoton
solut
administ
iv
sc
calv
correct
dehydr
electrolyt
abnorm
associ
neonat
diarrhea
solut
consid
weak
alkalin
fluid
lactat
eventu
metabol
bicarbon
liver
help
increas
blood
ph
howev
abil
lactat
produc
alkalin
effect
consid
weak
slow
due
metabol
requir
recommend
calv
sever
acidemia
kasari
naylor
although
lr
shown
success
correct
dehydr
electrolyt
abnorm
calv
disadvantag
note
includ
requir
iv
cathet
placement
special
equip
administr
anim
restraint
larg
amount
fluid
deliv
need
monitor
anim
administr
berchtold
rapid
deliveri
hyperton
salin
combin
oe
administr
shown
provid
superior
resuscit
compar
oe
fluid
therapi
leal
et
al
aydogdu
et
al
isoton
salin
flore
et
al
solut
combin
oe
effect
resuscit
sever
dehydr
calv
largevolum
lr
administr
less
expens
much
easier
faster
administ
hyperton
salin
also
indic
treatment
hyperkalemia
calv
commonli
seen
sever
dehydr
calv
constabl
et
al
leal
et
al
author
wit
mani
dairi
produc
particularli
larg
calf
ranch
routin
administ
l
lr
calv
diarrhea
either
iv
sc
instead
use
oral
electrolyt
howev
possibl
use
oral
oe
without
iv
hyperton
salin
calv
moder
dehydr
acidosi
equal
perhap
greater
benefit
small
volum
iv
sc
fluid
therefor
primari
purpos
studi
compar
abil
commerci
avail
oe
alon
combin
hyperton
salin
increas
plasma
volum
correct
acidemia
provid
nutrit
support
diarrheic
calv
compar
iv
sc
administr
lr
hypothes
oe
given
without
hyperton
salin
would
resuscit
calv
extent
give
iv
sc
lr
studi
protocol
approv
north
carolina
state
univers
institut
committe
care
use
laboratori
anim
studi
control
random
clinic
trial
perform
januari
octob
thirtytwo
healthi
holstein
bull
calv
holstein
heifer
calf
use
studi
femal
born
twin
bull
calf
suspect
freemartin
calv
rang
kg
bw
calv
hous
north
carolina
state
univers
research
barn
durat
studi
calv
acclim
hous
normal
diet
age
fed
l
milk
replac
contain
protein
fat
amplifi
max
calf
milk
replac
land
olak
anim
milk
arden
hill
mn
divid
feed
period
l
per
meal
per
day
throughout
acclim
period
durat
trial
calv
examin
induct
diarrhea
sign
clinic
diseas
exclud
studi
show
sign
ill
calv
purchas
birth
north
carolina
state
univers
dairi
farm
breed
heifer
farm
vaccin
wk
clostridi
vision
merck
anim
health
madison
nj
staphylococcu
aureu
lysigin
boehring
ingelheim
vetmedica
duluth
ga
bacterin
along
modifi
live
vaccin
contain
infecti
bovin
rhinotrach
ibr
bovin
viral
diarrhea
bvd
bovin
respiratori
syncyti
viru
brsv
combin
leptospira
bacterin
bovishield
gold
zoeti
parsippani
nj
vaccin
given
wk
age
breed
mo
age
heifer
receiv
anoth
dose
clostridi
staph
aureu
bacterin
along
kill
vaccin
contain
ibr
bvd
brsv
parainfluenza
viru
combin
leptospira
triangl
boehring
ingelheim
vetmedica
mo
gestat
heifer
given
gramneg
coreantigen
vaccin
jvac
boehring
ingelheim
vetmedica
along
bovin
coronaviru
rotaviru
enterotoxigen
e
coli
vaccin
scourguard
zoeti
vaccin
repeat
wk
calv
multipar
cow
receiv
kill
respiratori
vaccin
triangl
coreantigen
vaccin
coronaviru
rotaviru
e
coli
vaccin
time
dryoff
calv
studi
receiv
l
colostrum
birth
receiv
vaccin
transfer
colleg
veterinari
medicin
research
barn
within
h
birth
osmot
diarrhea
dehydr
induc
modif
protocol
use
extens
previou
calf
diarrhea
research
constabl
et
al
walker
et
al
b
leal
et
al
start
diarrhea
blood
collect
determin
serum
total
protein
concentr
diarrhea
induc
ad
sucros
g
sucros
per
kg
bw
milk
replac
feed
addit
calv
given
combin
diuret
drug
promot
dehydr
includ
spironolacton
mgkg
po
everi
h
patterson
vet
greeley
co
hydrochlorothiazid
dose
mgkg
po
everi
h
patterson
vet
furosemid
mgkg
im
everi
h
disal
inject
boehring
ingelheim
vetmedica
spironolacton
hydrochlorothiazid
tablet
crush
mix
ml
water
given
oral
syring
induct
diarrhea
continu
h
depend
sever
dehydr
depress
score
fecal
score
bodi
weight
hydrat
score
depress
score
fecal
consist
monitor
least
time
per
day
evalu
base
follow
scale
skin
tent
examin
perform
neck
hydrat
score
normal
eye
bright
recess
orbit
skin
feel
pliabl
mild
dehydr
slight
loss
skin
elast
skin
tent
durat
eye
normal
mildli
recess
orbit
moder
dehydr
skin
tent
eye
moder
recess
orbit
sever
dehydr
skin
tent
eye
markedli
recess
orbit
depress
score
normal
mild
depress
calf
suckl
vigor
moder
depress
calf
abl
stand
suckl
weak
disorgan
sever
depress
calf
unabl
stand
suckl
fecal
consist
normal
manur
normal
well
form
abnorm
fece
diarrhea
pasti
manur
softer
normal
mild
diarrhea
semiliquid
still
solid
compon
sever
diarrhea
pure
liquid
splash
hit
ground
form
solid
structur
model
reliabl
induc
diarrhea
moder
sever
dehydr
within
h
therefor
physic
examin
done
everi
h
calv
achiev
moder
dehydr
hydrat
score
plasma
volum
decreas
least
depress
score
least
fecal
consist
score
start
treatment
calf
jugular
cathet
place
facilit
blood
sampl
fluid
administr
calv
qualifi
enter
treatment
phase
studi
assign
follow
group
use
random
number
gener
group
n
calv
oral
electrolyt
calv
receiv
packet
oe
diaqu
boehring
ingelheim
vetmedica
mix
water
accord
label
direct
quart
ml
water
calv
allow
suckl
oe
fed
use
esophag
feeder
necessari
calv
weigh
kg
mean
sd
age
time
diarrhea
induct
group
n
calv
iv
fluid
calv
receiv
l
lr
jugular
cathet
period
calv
group
weigh
kg
mean
sd
age
time
diarrhea
induct
group
n
calv
sc
fluid
calv
receiv
l
lr
given
subcutan
fluid
administ
min
differ
site
ml
per
site
thorax
neck
calv
group
weigh
kg
mean
sd
age
time
diarrhea
induct
group
n
calv
oral
electrolyt
hyperton
salin
oeshss
calv
receiv
infus
hyperton
salin
jugular
cathet
dose
ml
per
kg
bw
min
immedi
follow
feed
oe
mix
water
accord
label
direct
quart
ml
water
calv
weigh
kg
mean
sd
age
time
diarrhea
induct
composit
oral
electrolyt
product
use
studi
compar
lr
hyperton
salin
tabl
time
enrol
treatment
group
administr
diuret
stop
blood
collect
baselin
treatment
time
h
treatment
determin
chang
plasma
volum
electrolyt
concentr
blood
ga
analysi
use
portabl
blood
chemistri
analyz
istat
abaxi
north
america
union
citi
ca
follow
measur
time
point
blood
ph
partial
pressur
co
pco
bicarbon
base
excess
hematocrit
hemoglobin
glucos
sodium
chlorid
potassium
anion
gap
concentr
anion
gap
ag
defin
differ
unmeasur
cation
unmeasur
anion
calcul
milliequival
per
liter
follow
data
analysi
correct
rectal
temperatur
bicarbon
valu
calcul
use
formula
log
hco
ph
log
pco
extracellular
base
excess
valu
hco
ph
chang
plasma
volum
time
point
determin
follow
formula
pt
serum
protein
concentr
induct
pt
x
serum
protein
concentr
measur
time
point
treatment
approxim
h
initi
therapi
calv
receiv
second
fluid
administr
within
assign
group
group
receiv
oe
group
receiv
anoth
l
lr
iv
blood
collect
second
treatment
well
h
second
treatment
assess
chang
fluid
therapi
plasma
volum
acidbas
statu
electrolyt
concentr
last
data
collect
calv
human
euthan
overdos
pentobarbit
euthasol
virbac
fort
worth
tx
intraven
cathet
data
assess
normal
distribut
proc
univari
sa
version
sa
institut
inc
cari
nc
outcom
continu
variabl
model
use
repeatedmeasur
anova
proc
mix
sa
treatment
time
interact
use
factor
covari
structur
among
repeat
measur
model
via
autoregress
model
least
squar
mean
estim
compar
treatment
time
treatment
overal
time
point
within
treatment
adjust
pvalu
tukey
method
present
ordin
respons
model
use
proport
odd
model
proc
genmod
sa
treatment
time
interact
use
explanatori
variabl
covari
structur
among
repeat
measur
model
via
independ
work
correl
matrix
probabl
estim
compar
treatment
time
treatment
overal
time
point
within
treatment
adjust
pvalu
tukey
method
present
calv
met
criteria
inclus
studi
h
largest
major
h
n
two
calv
requir
h
induct
met
criteria
begin
treatment
calv
develop
moder
metabol
acidosi
mean
sd
rang
show
clinic
sign
dehydr
includ
prolong
skin
tent
enophthalmo
mm
loss
least
bw
calv
maintain
weak
good
suckl
reflex
throughout
studi
one
calf
oe
group
fed
use
esophag
feeder
first
treatment
calv
also
continu
drink
normal
milk
allot
l
studi
period
calv
present
fecal
hydrat
attitud
score
start
diarrhea
induct
respons
osmot
diarrhea
protocol
note
almost
immedi
calv
fecal
score
seen
almost
calv
n
h
follow
induct
calv
h
follow
induct
tabl
fecal
score
end
studi
around
decreas
rapidli
remov
sucros
milk
occur
h
initi
treatment
hydrat
statu
least
calv
begin
treatment
period
calv
score
end
studi
hydrat
score
back
except
iv
group
significantli
differ
highest
median
hydrat
score
group
occur
begin
treatment
period
h
posttreat
attitud
score
variabl
begin
treatment
period
calv
score
score
score
median
attitud
score
group
around
entir
treatment
period
sever
plasma
volum
deplet
seen
group
compar
plasma
protein
concentr
induct
plasma
protein
level
begin
treatment
period
bw
decreas
time
diarrhea
induct
begin
treatment
across
group
calv
weigh
kg
mean
sd
induct
diarrhea
kg
time
initi
treatment
differ
group
kg
conclus
studi
chang
total
protein
ag
sodium
chlorid
potassium
hematocrit
bicarbon
concentr
summar
tabl
calv
present
increas
plasma
protein
concentr
compar
preinduct
valu
time
first
treatment
fastest
decreas
total
protein
note
iv
group
signific
differ
h
posttreat
sc
group
show
slower
decreas
plasma
protein
compar
group
iv
oeshss
group
faster
signific
improv
plasma
volum
begin
h
follow
treatment
oe
group
show
similar
improv
h
follow
treatment
figur
sc
fluid
group
slowest
show
increas
plasma
volum
statist
lower
h
first
treatment
h
follow
second
treatment
hematocrit
also
slower
decreas
sc
group
compar
group
oe
group
increas
blood
ph
bicarbon
base
excess
start
h
follow
initi
treatment
figur
glucos
level
significantli
affect
inclus
oe
figur
first
h
follow
treatment
expect
signific
differ
observ
sodium
concentr
follow
infus
hyperton
salin
interestingli
hyperton
salin
significantli
increas
chlorid
level
potassium
valu
affect
treatment
treatment
group
signific
effect
weight
attitud
hydrat
fecal
score
oe
group
signific
find
note
glucos
potassium
chlorid
blood
ph
plasma
volum
sodium
total
protein
glucos
significantli
increas
h
follow
treatment
potassium
level
decreas
significantli
h
follow
treatment
signific
effect
follow
second
treatment
chlorid
sodium
show
progress
decreas
significantli
lower
concentr
h
plasma
volum
show
rapid
increas
h
follow
oe
ingest
blood
ph
increas
start
h
follow
first
treatment
continu
improv
cours
treatment
period
intraven
fluid
also
effect
increas
plasma
volum
decreas
plasma
protein
level
soon
h
treatment
sc
treatment
show
decreas
hematocrit
total
protein
increas
plasma
volum
time
howev
improv
much
slower
occur
group
effect
sc
fluid
therapi
blood
ph
base
excess
bicarbon
signific
one
period
anoth
similar
iv
fluid
oeshss
treatment
particularli
effect
increas
plasma
volum
decreas
plasma
protein
level
soon
h
follow
infus
similar
oe
group
oeshss
group
show
rapid
reduct
potassium
level
begin
h
infus
glucos
level
also
increas
significantli
h
treatment
signific
find
studi
oe
without
hyperton
salin
superior
l
lr
given
iv
sc
rout
resuscit
calv
diarrhea
improv
plasma
volum
seen
oe
alon
almost
rapid
achiev
small
volum
iv
fluid
improv
blood
ph
glucos
concentr
much
faster
shown
previous
constabl
et
al
leal
et
al
aydogdu
et
al
hyperton
salin
effect
increas
abil
oe
improv
hydrat
statu
dehydr
calv
contrast
subcutan
fluid
administr
slow
increas
plasma
volum
blood
ph
studi
like
repres
poor
option
calv
treat
diarrhea
oral
electrolyt
solut
use
studi
mildli
hyperton
alkalin
oe
contain
lecithinco
citru
fiber
efficaci
oe
demonstr
previous
superior
perform
compar
electrolyt
product
constabl
et
al
bachmann
et
al
goodel
et
al
interfer
milk
clot
moder
osmol
advantag
label
direct
allow
mix
milk
provid
better
energi
supplement
weight
gain
goodel
et
al
seen
previou
studi
found
oe
demonstr
good
capac
improv
plasma
volum
replac
electrolyt
treat
moder
metabol
acidosi
support
blood
glucos
concentr
one
goal
formul
oe
optim
glucosesodium
cotransport
level
enterocyt
binder
et
al
oral
electrolyt
solut
well
design
optim
use
cotransport
allow
better
absorpt
electrolyt
glucos
neg
energi
balanc
loss
bw
common
find
calv
diarrhea
reduct
energi
intak
decreas
absorpt
nutrient
gut
sever
hypoglycemia
also
associ
increas
risk
mortal
calv
diarrhea
trefz
et
al
signific
advantag
use
oe
note
studi
increas
blood
glucos
level
follow
treatment
thu
provid
immedi
energi
find
support
use
oe
without
iv
fluid
help
supplement
glucos
energi
diarrheic
calf
note
l
lr
administ
intraven
studi
less
volum
requir
replac
fluid
deficit
calv
exampl
calv
weigh
kg
studi
time
initi
treatment
roughli
decreas
plasma
volum
therefor
calv
would
need
least
l
fluid
correct
deficit
account
ongo
loss
continu
diarrhea
given
greater
volum
lr
iv
might
seen
better
result
howev
elect
give
l
iv
fluid
close
mimic
done
field
scenario
although
previou
studi
compar
higher
volum
iv
lr
oeshss
shown
similar
result
one
studi
group
calv
given
mlkg
lr
first
hour
follow
mlkg
per
hour
addit
h
walker
et
al
calf
would
approxim
l
iv
lr
given
period
calv
treat
oeshss
studi
signific
increas
plasma
volum
sustain
significantli
longer
period
compar
group
receiv
infus
lr
recent
studi
gave
iv
lr
rate
mlkg
per
hour
h
l
total
calf
group
calv
natur
occur
diarrhea
aydogdu
et
al
second
group
calv
receiv
rate
acet
ringer
third
group
receiv
mlkg
oeshss
signific
increas
plasma
volum
note
oeshss
group
within
min
treatment
group
seen
studi
walker
et
al
oeshss
group
signific
sustain
increas
plasma
volum
either
group
receiv
iv
fluid
differ
sampl
time
studi
abl
see
increas
plasma
volum
min
postinfus
howev
notic
similar
effect
plasma
volum
oeshss
iv
fluid
group
h
posttreat
h
despit
rel
common
use
sc
fluid
calv
diarrhea
first
studi
includ
data
use
calv
small
anim
speci
sc
fluid
commonli
use
mildli
dehydr
patient
smith
greer
support
therapi
case
chronic
renal
diseas
cooley
et
al
recommend
use
sc
fluid
hypovolem
patient
limit
absorpt
associ
peripher
vasoconstrict
speci
dehydr
calv
studi
show
slow
progress
improv
sc
fluid
therapi
howev
effect
acidbas
statu
electrolyt
concentr
minim
h
studi
period
data
studi
indic
small
volum
sc
fluid
use
sole
treatment
rapid
correct
dehydr
metabol
acidosi
calv
diarrhea
osmot
diarrhea
model
util
studi
modifi
slightli
previous
publish
model
origin
model
includ
ad
sucros
milk
replac
g
per
kg
bw
along
use
furosemid
mgkg
im
everi
h
spironolacton
mgkg
po
everi
h
hydrochlorothiazid
mgkg
po
everi
h
model
extrem
effect
induc
sever
diarrhea
walker
et
al
use
multipl
studi
evalu
fluid
resuscit
calv
diarrhea
constabl
et
al
walker
et
al
although
model
effect
produc
profound
dehydr
calv
typic
develop
signific
metabol
acidosi
recent
studi
increas
dose
sucros
mgkg
increas
dose
spironolacton
mgkg
po
everi
h
hydrochlorothiazid
mg
kg
po
everi
h
elimin
use
furosemid
leal
et
al
newer
model
effect
produc
dehydr
calv
also
moder
acidosi
time
treatment
start
blood
ph
figur
chang
base
excess
concentr
follow
first
second
treatment
calv
osmot
diarrhea
treatment
oe
oral
electrolyt
n
iv
intraven
fluid
n
sc
subcutan
fluid
n
oeshss
oral
electrolyt
hyperton
salin
n
data
point
differ
uppercas
letter
ac
differ
significantli
treatment
group
data
point
differ
lowercas
letter
af
differ
significantli
experiment
time
point
p
error
bar
indic
se
induc
potassium
control
mechan
accord
find
even
aldosteron
markedli
elev
hyperkalem
calv
diarrhea
renal
excret
potassium
suffici
counterbal
system
increas
caus
sever
hypovolemia
addit
elev
level
dlactat
may
also
help
prevent
hyperkalemia
trefz
et
al
although
dlactat
concentr
measur
studi
like
significantli
elev
acidosi
seen
studi
sever
hypovolemia
observ
studi
like
explain
higher
level
potassium
seen
time
initi
treatment
elev
potassium
concentr
decreas
treatment
time
decreas
fastest
significantli
faster
oe
oeshss
potenti
limit
studi
use
experiment
model
osmot
diarrhea
instead
calv
natur
occur
diarrhea
although
protocol
use
extens
previou
studi
examin
differ
approach
fluid
resuscit
diarrheic
calv
constabl
et
al
walker
et
al
b
leal
et
al
could
argu
reproduc
exact
metabol
alter
seen
calv
diarrhea
mani
acquir
case
neonat
diarrhea
calv
hyponatremia
elev
level
dlactat
elev
ag
trefz
et
al
although
dlactat
measur
studi
sodium
level
within
normal
rang
calv
rel
mild
acidemia
overal
compar
calv
sever
dehydr
field
therefor
model
might
induc
signific
dehydr
sever
acidemia
howev
previou
studi
demonstr
relationship
sever
acidosi
degre
dehydr
naylor
grovewhit
white
emphas
howev
calv
sever
acidosi
need
iv
sodium
bicarbon
trefz
et
al
smith
berchtold
clinic
often
defin
blood
ph
calf
unabl
stand
physic
examin
calv
unlik
benefit
sole
oe
anoth
potenti
limit
treatment
use
studi
equal
outlin
tabl
differ
sodium
chlorid
potassium
glucos
buffer
concentr
along
vari
strong
ion
differ
osmol
although
treatment
vari
chosen
repres
common
treatment
given
calv
diarrhea
north
america
primari
purpos
studi
compar
commonli
administ
treatment
use
field
ensur
treatment
equival
term
sodium
concentr
certainli
approach
lead
limit
term
interpret
data
exampl
group
calv
receiv
oe
much
greater
increas
plasma
glucos
concentr
calv
receiv
small
volum
iv
sc
lr
howev
addit
dextros
ad
lr
solut
result
would
like
differ
therefor
assum
oe
alway
superior
iv
fluid
therapi
conclus
extend
treatment
group
util
studi
small
volum
lr
given
iv
sc
long
diarrhea
recogn
quickli
qualiti
electrolyt
solut
use
oe
consid
treatment
choic
treat
diarrhea
calv
effect
increas
plasma
volum
correct
moder
metabol
acidemia
electrolyt
abnorm
increas
blood
glucos
concentr
seen
studi
sever
dehydr
calv
combin
oe
hyperton
salin
ml
kg
increas
speed
effici
increas
plasma
volum
compar
oe
alon
howev
practic
treat
calv
l
lr
given
iv
sc
sole
treatment
diarrhea
recommend
oral
electrolyt
product
remain
gold
standard
resuscit
calv
diarrhea
effect
rapidli
correct
mild
moder
dehydr
acidemia
small
infus
iv
fluid
use
effect
combin
oe
sever
dehydr
calv
hyperton
salin
combin
oe
improv
efficaci
howev
calv
sever
acidemia
intraven
bicarbon
solut
indic
subcutan
fluid
absorb
slowli
studi
appear
effect
rapid
resuscit
calv
diarrhea
use
alon
like
repres
poor
treatment
option
use
support
therapi
follow
initi
correct
hypovolemia
metabol
acidosi
